• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Urine odor analyzer might better diagnose bladder cancer | MassDevice.com On Call

Urine odor analyzer might better diagnose bladder cancer | MassDevice.com On Call

July 10, 2013 By Sony Salzman

MassDevice On Call

MASSDEVICE ON CALL — Inspired by studies demonstrating canine abilities to sniff out cancerous biomarkers, a team of U.K. researchers developed a scent-analysis device that they say can diagnose early signs of bladder cancer.

In a test of nearly 100 urine samples, the device, called OdorReader, was 100% accurate in distinguishing which samples came from cancer patients, researchers said. As an added bonus, the system delivers its diagnosis in just 30 minutes, according to a press release.

Researchers hope the technology may be able to detect cancer earlier than current urine-testing methods.

"Each year approximately 10,000 people in the UK are diagnosed with bladder cancer," University of Liverpool’s Institute of Translational Medicine professor Chris Probert said in prepared remarks. "It is a disease that, if caught early, can be treated effectively, but unfortunately we do not have any early screening methods other than diagnosis through urine tests at the stage when it starts to become a problem."

The device, which features a sensor that interprets fumes from urine and attempts to detect the presence of cancerous cells, may be able to dramatically cut bladder cancer treatment costs, according to the release.

"Bladder cancer is said to be the most expensive cancer to treat, due to repeated scopes to inspect the development of the cancer cells in the bladder," Probert added. "OdorReader has the potential to dramatically cut these costs by preventing scopes."

 Non-surgical specialists perform almost half of sarcoma surgeries
Dangerous sarcomas, located deep in muscle tissue, are removed by surgeons specifically trained to do so in only 52% of cases, according to a review by the University of Southern California Davis Health System.

The other 48% of sarcoma removals were in the hands of non-oncological surgeons, such as orthopedic or plastic surgeons. This data led the U.S. National Comprehensive Cancer Network to rethink guidelines for soft tissue sarcomas.
Read more

 Embedded code might be tracking health-related web browsing
Popular health-related websites are rife with 3rd-party programs that quietly track use and gather data,
, according to research from Marco Huesch from the University of Southern California.

Huesch found that 3rd-parties are embedding code that gathers browsing patterns on highly-trafficked medical websites. Of the 20 popular health websites he examined, all had an average of 6 or 7 embedded programs that tracked potentially sensitive data.
Read more

 2 new small biotechs opening doors in Mass.
ZS Genetics and Boston Biomedical this week both celebrated ribbon-cutting ceremonies at brick-and-mortar locations in Massachusetts.

ZS Genetics, a DNA sequencing company, opened doors in Wakefield for its 10 employees, who have been working remotely since the company founded 6 years ago.

Boston Biomedical’s new location will also serve as the global oncology center for parent company Dainippon Sumitomo Pharma, which bought out the small Boston Biomedical last year. Boston Biomedical has been operating out of the Cambridgeport office since winter, but the ribbon-cutting ceremony was delayed because of this year’s snowstorms.
Read more

 SmartMetric is selling its EMR key ring to the public
SmartMetric is taking to the airwaves with a radio campaign surrounding its portable electronic health record keyring. The keyring, about the size of a flash drive, is protected with a fingerprint "key" that unlocks the files.

Similar to a metal medical wristband, the keyring is for people who want to keep important medical information with them at all times. Company CEO Chaya Hendrick said a radio campaign is the most direct way to reach customers.
Read more

Filed Under: Biotech, Diagnostics, Electronic Medical Records (EMR), News Well, Oncology Tagged With: On Call

More recent news

  • AdvaMed calls for medtech tariff exemptions at Senate hearing
  • GE HealthCare, Raydiant Oximetry partner on fetal oxygen saturation tech
  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year
  • Axoft makes Fleuron BCI material available for purchase, inks license deal with Stanford

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy